Trades on 3 secondary markets

Hexagon Bio

Hexagon Bio is a Menlo Park, California biotechnology company developing novel payloads for antibody-drug conjugates (ADCs) in oncology. The company designs next-generation ADC payloads intended to overcome resistance to current payloads and to expand the range of cancer indications ADCs can treat.

minimal 7.2 / 100 0 APIs View provider profile →

Company Health Tech Biotechnology Oncology Antibody-Drug Conjugates Drug Discovery

Hexagon Bio is an API provider whose private shares are listed on 3 secondary markets: Forge Global, EquityZen, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.